Empire Financial Management Company’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Sell
13,518
-4,500
-25% -$401K 0.26% 106
2025
Q4
$1.42M Hold
18,018
0.31% 89
2025
Q3
$1.44M Hold
18,018
0.33% 89
2025
Q2
$1.64M Sell
18,018
-318
-2% -$29K 0.47% 68
2025
Q1
$1.72M Sell
18,336
-5,500
-23% -$492K 0.53% 63
2024
Q4
$2.17M Buy
23,836
+7,500
+46% +$716K 0.68% 46
2024
Q3
$1.7M Sell
16,336
-500
-3% -$51K 0.52% 61
2024
Q2
$1.63M Sell
16,836
-7,500
-31% -$692K 0.54% 60
2024
Q1
$2.19M Buy
24,336
+15,000
+161% +$1.27M 0.72% 41
2023
Q4
$744K Hold
9,336
0.29% 92
2023
Q3
$664K Sell
9,336
-35
-0.4% -$2.62K 0.29% 91
2023
Q2
$722K Hold
9,371
0.29% 88
2023
Q1
$704K Buy
+9,371
New +$697K 0.29% 90

Other funds holding CL

Empire Financial Management Company's CL Position: Q1 2026 in Review

Empire Financial Management Company reduced its Colgate-Palmolive (CL) stake by 25% in Q1 2026, selling an estimated $401K and leaving 13,518 shares worth $1.15M. The position accounts for 0.26% of the portfolio, ranked #106.

Empire Financial Management Company first reported a position in CL in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.19M in Q1 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Empire Financial Management Company held 13,518 shares of Colgate-Palmolive worth $1.15M as of Q1 2026.
  • Empire Financial Management Company sold 4,500 Colgate-Palmolive shares in Q1 2026, an estimated $401K.
  • Colgate-Palmolive made up 0.26% of Empire Financial Management Company's portfolio in Q1 2026, its #106 holding.
  • Empire Financial Management Company first reported a position in Colgate-Palmolive in Q1 2023 and has held it in 13 quarters since.
  • Empire Financial Management Company's Colgate-Palmolive position peaked at $2.19M in Q1 2024.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Empire Financial Management Company's 13F filing for Q1 2026, filed 18 May 2026.